Rajiv Mallick

Summary

Affiliation: Wyeth Research
Country: USA

Publications

  1. ncbi request reprint Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin
    Rajiv Mallick
    Wyeth Research, Collegeville, PA 19426 3982, USA
    Surg Infect (Larchmt) 8:159-72. 2007
  2. ncbi request reprint Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo
    Rajiv Mallick
    Global Health Outcomes Assessment, Wyeth Research, Collegeville, PA, USA
    J Clin Psychiatry 64:321-30. 2003
  3. doi request reprint Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections
    John Edelsberg
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Surg Infect (Larchmt) 9:335-47. 2008
  4. ncbi request reprint Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Am J Health Syst Pharm 59:941-8. 2002
  5. ncbi request reprint Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9119, USA
    J Clin Psychopharmacol 24:497-506. 2004
  6. ncbi request reprint Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections
    Helio S Sader
    JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA
    Int J Antimicrob Agents 30:514-20. 2007
  7. doi request reprint Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections
    John Edelsberg
    Policy Analysis, Brookline, Massachusetts 02445, USA
    Infect Control Hosp Epidemiol 29:160-9. 2008
  8. doi request reprint Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia
    Cristina Tanaseanu
    Department of Internal Medicine, St Pantelimon Clinical Emergency Hospital, Bucharest OP 22, Romania
    Diagn Microbiol Infect Dis 61:329-38. 2008

Collaborators

  • Karl Weiss
  • A F Schatzberg
  • M H Trivedi
  • H S Sader
  • J Menzin
  • T R Fritsche
  • R N Jones
  • John Edelsberg
  • Ariel Berger
  • Cristina Tanaseanu
  • Andreas Kuznik
  • Gerry Oster
  • Kathleen Lang
  • Colby H Grossman
  • Hristo Metev
  • João Adriano de Barros
  • Waldo Luis Leite Dias de Mattos
  • Roderick V Clark
  • David J Weber
  • Hassan Gandjini
  • Patricia Elena Fernandez Vasquez
  • Ileana Rebedea
  • Ernesto Julio Jakob
  • Antonio Tarcisio de Faria Freire
  • Fernando Cruz Mendo Urbina
  • Daniel Paulovic
  • Thomas M File
  • Abel Jasovich
  • Nora Patricia Quintero Perez
  • Peter S Vrooman
  • Valentina Ionescu
  • C Lynn
  • Francesc Gudiol
  • John A Gezon
  • Visnja Skerk
  • Eduardo Rómulo Ticona Chavez
  • John F Reinhardt
  • Lloyd E Hayes
  • Maria Isabel Campos
  • Hans Snyman
  • Dimitar Popov
  • Anthony S Ramage
  • Julio Ramirez
  • David Griffith
  • Jan Kus
  • Donald Levine
  • Robert L Penn
  • Carlos Bergallo
  • John Abernethy
  • Sandor Molnar
  • Maria Eugenia Oliva
  • Marius Zolubas
  • Robert A Kearl
  • Igor Bokarev
  • Prabha Adhikari
  • Yin Ching Chuang
  • Coman Tanasescu
  • Sorin Rugina
  • Rosen Marinov
  • Syed W A Zaidi
  • Daniel G Lorch
  • Anatoly Tokmalaev
  • Vladimir Nonikov
  • Arvind K Gupta
  • Marcin Regulski
  • Larry I Cowan
  • Maria Auxiliadora Carmo Moreira
  • Doria Grimard
  • Kamil Klenha
  • Markian R Bochan
  • Marta Bisits
  • Johannes M Engelbrecht
  • Carlos Alberto Morales Paris
  • Carlos Ernesto Ferreira Starling
  • Willem J Rabie
  • Andrew McIvor
  • Gary Dukart
  • Roberto Stirbulov
  • Enn Pyttsep
  • Terezie Janaskova
  • V Anderson
  • Bangalore R S Murthy
  • Francis L Counselman
  • Alla Tsoi
  • Vicenc Falco I Ferrer
  • Valeriy Chernyak
  • Amalia Rodriguez French
  • Gregory J Moran
  • Salah Bibi
  • Libor Kamenik

Detail Information

Publications8

  1. ncbi request reprint Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin
    Rajiv Mallick
    Wyeth Research, Collegeville, PA 19426 3982, USA
    Surg Infect (Larchmt) 8:159-72. 2007
    ..Duration of intravenous (IV) treatment, surgical/radiologic interventions for infection control, and hospital length of stay (LOS) are important cost considerations in complicated intra-abdominal infections (cIAIs)...
  2. ncbi request reprint Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo
    Rajiv Mallick
    Global Health Outcomes Assessment, Wyeth Research, Collegeville, PA, USA
    J Clin Psychiatry 64:321-30. 2003
    ....
  3. doi request reprint Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections
    John Edelsberg
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Surg Infect (Larchmt) 9:335-47. 2008
    ..Initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infection (cIAI) usually is empiric. We explored the economic consequences of failure of such therapy in this patient population...
  4. ncbi request reprint Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Am J Health Syst Pharm 59:941-8. 2002
    ..Gemtuzumab ozogamicin appeared to be associated with equivalent survival and fewer total days of hospitalization than conventional chemotherapy in adults with relapsed AML...
  5. ncbi request reprint Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9119, USA
    J Clin Psychopharmacol 24:497-506. 2004
    ..The purpose of this retrospective analysis was to estimate the cost and effectiveness of venlafaxine extended-release (VXR) compared with selective serotonin reuptake inhibitors in the outpatient treatment of major depressive disorder...
  6. ncbi request reprint Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections
    Helio S Sader
    JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA
    Int J Antimicrob Agents 30:514-20. 2007
    ..1%) and imipenem in Spain (87.7%). Our results suggest that tigecycline represents a viable additional option for the empirical treatment of cSSSI in these countries...
  7. doi request reprint Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections
    John Edelsberg
    Policy Analysis, Brookline, Massachusetts 02445, USA
    Infect Control Hosp Epidemiol 29:160-9. 2008
    ..To estimate the consequences of failure of initial antibiotic therapy for patients with complicated skin and skin-structure infections...
  8. doi request reprint Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia
    Cristina Tanaseanu
    Department of Internal Medicine, St Pantelimon Clinical Emergency Hospital, Bucharest OP 22, Romania
    Diagn Microbiol Infect Dis 61:329-38. 2008
    ..6% TGC versus 6.9% LEV) were significantly higher in LEV. Discontinuations for AEs were low (TGC, 26 patients [6.1%]; LEV, 34 patients [8.1%]). TGC appeared safe and achieved cure rates similar to LEV in hospitalized patients with CAP...